The global acute sinusitis market is expected to exhibit a robust 7.89% CAGR over the forecast period from 2021 to 2027, according to the latest research report from Market Research Future (MRFR). The MRFR report looks into the major drivers and restraints propelling and hindering the global acute sinusitis market’s growth prospects over the forecast period, to deliver a reliable background of the market and to analyze the market’s growth prospects over the forecast period.
Acute sinusitis is an upper respiratory infection affecting allergy sufferers, hay fever patients, patients with a deviated nasal septum, patients with cystic fibrosis, and patients with infected adenoids, among others. Acute sinusitis is an inflammation of the membranes lining the nose and the sinuses around it. It manifests as nasal congestion, headache, and feelings of tenderness behind the eyes and other sinuses in the face, including around the cheeks and the forehead. According to the American Academy of Otolaryngology, acute sinusitis affects around 1 in 8 adults every year. The disease can be diagnosed by allergy testing, MRI/CT scans, or nasal endoscopy, and is treated with saline nasal sprays, allergy shots, decongestants, antibiotics, etc.
The growing prevalence and increasing medical burden of acute sinusitis is likely to be the major driving factor for the global acute sinusitis market over the forecast period. While acute sinusitis is not a life-threatening condition, its short-term effects can be highly unpleasant and painful for the sufferer, as various cavities around the mouth and nose may be affected by the disease, causing widespread pain. As a result, there has been a significant rush to develop effective measures to be taken against acute sinusitis, such as nasal sprays, decongestants, and pain relievers. This is likely to be a major driver for the global acute sinusitis market over the forecast period, as this area of medical product development has garnered strong prospects over the last few years and has thus become immensely profitable, leading to growing involvement from major players in the global healthcare sector.
Segmentation:
The global acute sinusitis treatment is segmented on the basis of diagnosis, end user, and region.
On the basis of diagnosis, the acute sinusitis market is segmented into nasal endoscopy, imaging tests, laboratory tests, and allergy testing. Imaging tests are further segmented into CT and MRI.
On the basis of treatment, the acute sinusitis market is segmented into saline nasal spray, nasal corticosteroids, decongestants, OTC pain relievers, allergy shots, antibiotics, and others.
On the basis of end user, the market is segmented into hospitals and clinics, research centers, and others. Hospitals hold the leading share in the global acute sinusitis market and are likely to remain the dominant end user in the global market over the forecast period.
Regional Analysis:
The global acute sinusitis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas segment holds the major share in the global acute sinusitis market and is likely to remain the dominant contributor to the global market over the forecast period due to the growing awareness about acute sinusitis and the increasing availability of acute sinusitis treatments in the region. The growing awareness about the possible complications of allergies in the Americas region is also likely to be a major driver for the acute sinusitis market in the region over the forecast period.
Europe also holds a considerable share in the global acute sinusitis market and is likely to grow at a stable rate over the forecast period due to the increasing awareness about the disease and the increasing ease of procuring effective medication such as nasal sprays and decongestants. The widespread availability of OTC pain relief medication, decongestants, and nasal sprays in Europe is likely to be the key driver for the acute sinusitis market in the region over the forecast period.
Competitive Analysis:
Leading players in the global acute sinusitis market include Sanofi, Bayer AG, Bristol-Myers Squibb, AstraZeneca plc, Novartis AG, Reddy’s Lab, Merck & Co. Inc., Eli Lilly and Company, and Abbott.
Industry Updates:
A report published in February 2019 found that excessively long prescriptions for antibiotics for relatively minor diseases such as acute sinusitis may be causing mass-scale antibiotic resistance among pathogens. The use of nasal sprays, decongestants, and other physical means of mitigating the problem is likely to grow in the acute sinusitis market over the forecast period as a result.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments